With more than 200 products in the pipeline and more than $2B invested in early stage companies in the U.S. to date, digital therapeutics (DTx) are poised to generate a wave of new treatment options for patients and providers. Yet many challenges remain for these solutions to gain the type of traction needed for their promise to be realized. During this on-demand webinar, we explore the future of digital therapeutics and pharma’s opportunity to shape it.
Viewers will learn:
- The latest DTx trends and activity across therapy areas, as well as pharma activity in DTx
- The opportunity (or threat) of DTx for pharma
- How to overcome pharma-specific barriers in DTx development and commercialization